Xconomy: Sermo Aims to Launch New Version of Doctors-Only Social Networking Site
Summary
Sermo Aims to Launch New Version of Doctors-Only Social Networking Site (Page 2 of 2) have to take on any more cash,” Palestrant says.Sermo’s main clientele are large pharmaceutical outfits that pay for access to the firm’s online community of more than 112,000 doctors and growing.Depending on the figures you use, the number of registered doctors on the site equals somewhere in the neighborhood of a quarter of all practicing physicians in the U.S., according to Palestrant.And drug companies are expected to increase their spending on Internet marketing, especially as they reduce their legions of field salespeople to trim their own budgets.The pharmaceutical business, for one, has been rocked by competition between lower-priced generic drug and the marquee products that have supported outsized budgets at companies such as Eli Lilly, Merck, and Pfizer, to name a few of the biggies.